medwireNews: The FINEARTS-HF trial has shown a reduced risk for cardiovascular death and heart failure (HF) events with finerenone use in people with HF and a mildly reduced or preserved ejection fraction.
04-09-2024 | Heart Failure | News
04-09-2024 | Heart Failure | News
medwireNews: The FINEARTS-HF trial has shown a reduced risk for cardiovascular death and heart failure (HF) events with finerenone use in people with HF and a mildly reduced or preserved ejection fraction.